NYSE American: NanoViricides Inc. In Light Of The Continuing Need For COVID Treatment, NNVC) Begins Long-Awaited Oral Clinical Trials For Its Antiviral Nanomedicine NV-CoV-2
A new nanomedical treatment is being developed by NanoViricides NNVC, a pharmaceutical company. It as of late refreshed the world ...